EGFR and small cell lung carcinoma: In summary, the histological, clinical, and genomic characteristics of EGFR-mutated patients who transform to SCLC on EGFR therapy are unique and complex, with each individual having a distinct time to transformation without a concrete genomic profile to identify patients at risk for transformation.